CPI launches its Advanced MedTech Manufacturing Centre

At MEDICA 2024, CPI will announce the launch of its state-of-the-art  Advanced MedTech Manufacturing Centre, a cutting-edge facility designed to accelerate MedTech innovation. The Centre brings together design and development, novel component production, and clean assembly in one location. It features capabilities in rapid prototyping, additive manufacturing, flexible-hybrid electronics assembly, and post-processing equipment, all operated by multidisciplinary teams of scientists and engineers. 

CPI’s dedicated facilities for diagnostic device development, including electrochemical biosensors, liquid assays, and microfluidic systems, are supported by biolabs for testing devices with human samples. This comprehensive approach helps to de-risk product development, reduce time to market, and minimise capital expenditure. CPI is the key strategic partner for new technology and product development for global leaders and emerging companies. With a team of 700 multidisciplinary experts and €260 million in cutting-edge assets across biology, formulation, materials and digital technologies within its national innovation centres, CPI creates patient-centred and sustainable solutions to surpass others in market differentiation.  

As part of the UK’s High Value Manufacturing Catapult, CPI is skilled in building innovative collaborations and brings deep experience in convening industrial and scientific multi-party partnerships to connect with the NHS. CPI works with its partners to solve high-risk significant challenges, bringing leading technologies and products to the healthcare market. 

Alex Cole, Director of Market Strategy at CPI, added: “This year marks a major milestone in CPI’s journey – our 20th Anniversary. Over the last two decades we have built a substantial track record of working with deep tech innovations, including those in HealthTech, and accelerating them to market. 

“We have now brought together all our major capabilities in one place to better serve global healthtech innovation needs. At a point where there’s so much potential to improve patient lives through personalisation of care, connected devices, wearables, and AI/ML and digital – our MedTech Manufacturing Innovation Centre could not be launching at a better time, and we’re excited to be at the forefront of this innovative revolution.” 

Emma Kocsi-Martin, Exhibition and Events Manager, from Medilink commented, “We are delighted CPI have joined us this year on the UK Pavilion in this their 20th Anniversary, and encouraged to see CPI growing its capabilities substantially over that time. We wish them all the best and look forward to helping with driving footfall to their stand, together with bespoke high-quality support to them and all our exhibitors with our experience and knowledge built up over 20 years. 

Medilink UK is the exclusive UK partner by Messe Düsseldorf for MEDICA 2024 in Germany. The partnership also includes other medical trade fairs worldwide organised by Messe Düsseldorf through MEDICAlliance, including Medical Fair Asia, Medical Fair India and Rehacare. 

MEDICA welcomed over 83,000 visitors from almost 70 countries in 2023 and this year will be held again in Düsseldorf, Germany from the 11th to the 14th of November 2024 representing an excellent opportunity for UK healthcare manufacturers and providers to showcase the very best of talent and innovation to a global audience. 

CPI at MEDICA 2024 in Hall 15 stand number C12.3. 

www.uk-cpi.com